Medicare Enrolled
Dr. Bashar Omarbasha, MD
Urology Physician · Oneida, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Omarbasha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Omarbasha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Omarbasha
Dr. Bashar Omarbasha is an urology physician in Oneida, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Omarbasha performed 5,941 Medicare services across 2,939 unique beneficiaries.
Between the years covered by Open Payments, Dr. Omarbasha received a total of $15,286 from 60 pharmaceutical and/or device companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Omarbasha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in NY
$15,286 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,941
Medicare services
Top 15% in NY for urology physician
2,939
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~297 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
1,701 | $5 | $10 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,251 | $2 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
695 | $60 | $180 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
535 | $87 | $265 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
309 | $8 | $11 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
208 | $7 | $42 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
149 | $23 | $130 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
132 | $46 | $123 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
128 | $168 | $703 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
126 | $47 | $124 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
84 | $77 | $260 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
74 | $296 | $1,232 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
59 | $73 | $228 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
50 | $39 | $2,274 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
48 | $7 | $87 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
43 | $65 | $215 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $37 | $106 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
36 | $33 | $94 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
32 | $10 | $61 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
25 | $25 | $350 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
25 | $149 | $400 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
24 | $284 | $767 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
23 | $575 | $2,050 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
18 | $37 | $153 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $106 | $388 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
16 | $292 | $988 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
16 | $44 | $125 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
15 | $437 | $1,756 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
15 | $58 | $184 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
14 | $156 | $2,986 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
12 | $95 | $405 |
| Ultrasound of penis artery and vein blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins of the penis. |
12 | $91 | $297 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
11 | $70 | $223 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
36.3% medium
63.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,286
Total received (2018-2024)
Avg $2,184/year across 7 years
Top 14% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
455
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,338 (93.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$948 (6.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,764
2023
$3,295
2022
$2,080
2021
$1,434
2020
$817
2019
$3,713
2018
$2,183
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$330
COLOPLAST CORP
$301
Dendreon Pharmaceuticals LLC
$158
ABBVIE INC.
$131
Boston Scientific Corporation
$107
UROGEN PHARMA, INC.
$72
Myriad Genetic Laboratories, Inc.
$71
Merck Sharp & Dohme LLC
$62
ACCORD HEALTHCARE, INC.
$52
VERTEX PHARMACEUTICALS INCORPORATED
$52
Endo USA, Inc.
$52
Ferring Pharmaceuticals Inc.
$50
Astellas Pharma US Inc
$45
Antares Pharma, Inc.
$44
180 Medical, Inc.
$41
Tolmar, Inc.
$34
PFIZER INC.
$32
Olympus America Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$24
Telix Pharmaceuticals
$23
Sumitomo Pharma America, Inc.
$20
Endo Pharmaceuticals Inc.
$20
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 44.8% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$2,552
Coloplast Corp
$2,203
Teleflex LLC
$890
Axonics, Inc.
$782
Boston Scientific Corporation
$753
Astellas Pharma US Inc
$735
Medtronic, Inc.
$712
Antares Pharma, Inc.
$501
PFIZER INC.
$485
COLOPLAST CORP
$396
Janssen Biotech, Inc.
$332
AbbVie Inc.
$295
Endo Pharmaceuticals Inc.
$290
Dendreon Pharmaceuticals LLC
$289
Myriad Genetic Laboratories, Inc.
$273
Merck Sharp & Dohme LLC
$227
Bayer HealthCare Pharmaceuticals Inc.
$219
ABBVIE INC.
$214
UROVANT SCIENCES INC
$185
TOLMAR Pharmaceuticals, Inc.
$180
ACCORD HEALTHCARE, INC.
$158
UROGEN PHARMA, INC.
$149
NxThera, Inc.
$138
UroGen Pharma, Inc.
$134
Palette Life Sciences, Inc.
$130
Axonics Modulation Technologies, Inc.
$128
GENZYME CORPORATION
$125
AbbVie, Inc.
$121
Caldera Medical, Inc
$121
Medtronic USA, Inc.
$103
Myovant Sciences Inc.
$98
DENTSPLY IH Inc.
$96
Avadel Specialty Pharmaceuticals, LLC
$94
Sumitomo Pharma America, Inc.
$92
Telix Pharmaceuticals
$77
Ferring Pharmaceuticals Inc.
$74
180 Medical, Inc.
$73
Clarus Therapeutics Inc.
$68
Allergan, Inc.
$60
Rigicon,Inc.
$59
Olympus America Inc.
$56
Supernus Pharmaceuticals, Inc.
$52
VERTEX PHARMACEUTICALS INCORPORATED
$52
Endo USA, Inc.
$52
Tolmar, Inc.
$49
PROCEPT BioRobotics Corporation
$44
Bayer Healthcare Pharmaceuticals Inc.
$42
Bard Access Systems, Inc.
$40
BOSTON SCIENTIFIC CORPORATION
$37
Smith+Nephew, Inc.
$33
Kowa Pharmaceuticals America, Inc.
$32
Blue Earth Diagnostics Limited
$31
Merck Sharp & Dohme Corporation
$27
Amgen Inc.
$23
Mission Pharmacal Company
$20
Kerecis Limited
$19
ConvaTec Inc.
$18
Janssen Scientific Affairs, LLC
$17
AstraZeneca Pharmaceuticals LP
$15
Novo Nordisk Inc
$15
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
ABIRATERONE ACETATE TABLETS · ADSTILADRIN · ALTIS · AQUACEL FOAM PRO · AVEED · Altis · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · BRACANALYSIS CDX · BRIDION · Bulkamid · CAMCEVI · Coloplast TFL Drive · Desara · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL THERAPIES · GENERAL ERECTILE DYSFUNCTION · GENERAL THERAPIES · GENERAL - ERECTILE DYSFUNCTION · GENTLECATH · GENTLECATH GLIDE · General - BPH · General - Erectile Dysfunction · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · Kerecis Omega3 SurgiClose · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PREMARIN · PROLARIS · PROVENGE · Prolaris · Rezum · Rigi10 Malleable Penile Prosthesis · SEGLENTIS · SOLYX · Saffron · Santyl · Seglentis · SpeediCath · TITAN · TLANDO · TOVIAZ · Titan · UROLIFT · UroLift · UroLift System · Urocit-K · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
54
Per 100K population
79.9
County median income
$73,141
Nearest hospital
ONEIDA HEALTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Omarbasha is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NY), with low-engagement industry engagement in the top 14% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Omarbasha experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Omarbasha performed 1,701 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Omarbasha receive payments from pharmaceutical companies?
Yes. Dr. Omarbasha received a total of $15,286 from 60 companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Omarbasha's costs compare to other urology physicians in Oneida?
Dr. Omarbasha's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Omarbasha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Oneida
Browse urology physicians in Oneida ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology